Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-19-000470
Filing Date
2019-04-25
Accepted
2019-04-25 16:11:08
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND I, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE GP II, LLCCORMORANT PRIVATE HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 158591
2 exhibit99.htm EX-99.1 9389
  Complete submission text file 0000929638-19-000470.txt   170164
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Subject) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90986 | Film No.: 19767555
SIC: 2834 Pharmaceutical Preparations